Application 218820

Type
NDA
Sponsor
NEUROCRINE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CRENESSITYCRINECERFONTSOLUTION;ORAL50MG/MLYesYes

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
80833ORIG 2025-01-10
80598ORIG 2024-12-16
80575ORIG 2024-12-13